The impact of membrane permeability and dialysate purity on cardiovascular outcomes

Journal of the American Society of Nephrology

Volumn 24, Issue 6, 2013, Pages 1014-1023

  Asci, Gulay ^a   Töz, Huseyin ^a   Ozkahya, Mehmet ^a   Duman, Soner ^a   Demirci, Meltem Sezis ^a   Cirit, Mustafa ^b   Sipahi, Savas ^a   Dheir, Hamad ^a   Bozkurt, Devrim ^a   Kircelli, Fatih ^a   Ok, Ebru Sevinc ^a   Erten, Sinan ^c   Ertilav, Muhittin ^a   Kose, Timur ^a   Basci, Ali ^a   Raimann, Jochen G ^d   Levin, Nathan W ^d   Ok, Ercan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Sevgi Dialysis Clinic   (Turkey)

^d RENAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRANSFERRIN;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIALYSATE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EVENT FREE SURVIVAL; FACTORIAL DESIGN; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERPHOSPHATEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VASCULAR ACCESS;

EID: 84878743622     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012090908     Document Type: Article

References (23)

1. US Renal Data System: Overall hospitalization and mortality. Am J Kidney Dis 42[Suppl 5]: S1-S230, 2003
2. Bouré T, Vanholder R: Biochemical and clinical evidence for uremic toxicity. Artif Organs 28: 248-253, 2004
3. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LY, Jones C, Orzol SM, Held PJ: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: Results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis 37: 276-286, 2001
4. Chauveau P,NguyenH, Combe C,ChêneG, Azar R, CanoN, Canaud B, Fouque D, Laville M, Leverve X, Roth H, Aparicio M; French Study Group for Nutrition in Dialysis: Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 45: 565-571, 2005
5. Krane V, Krieter DH,OlschewskiM,MarzW,Mann JF, Ritz E, Wanner C: Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 49: 267-275, 2007
6. Blankestijn PJ, Ledebo I, Canaud B: Hemodiafiltration: Clinical evidence and remaining questions. Kidney Int 77: 581-587, 2010
7. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, AllonM, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, LevinNW, MilfordE,OrntDB,RoccoMV,Schulman G,SchwabSJ, TeehanBP, Toto R; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
8. Cheung AK, Levin NW, Greene T, Agodoa L, Bailey J, Beck G, Clark W, LeveyAS, Leypoldt JK,OrntDB,RoccoMV,SchulmanG, Schwab S,Teehan B, Eknoyan G: Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO study. J Am Soc Nephrol 14: 3251-3263, 2003
9. Delmez JA, Yan G, Bailey J, Beck GJ, Beddhu S, Cheung AK, Kaysen GA, Levey AS, Sarnak MJ, Schwab SJ; Hemodialysis (HEMO) Study Group: Cerebrovascular disease in maintenance hemodialysis patients: Results of the HEMO Study. Am J Kidney Dis 47: 131-138, 2006
10. Cheung AK, SarnakMJ, Yan G, BerkobenM,Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D, Levey AS; HEMO Study Group: Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study. Kidney Int 65: 2380-2389, 2004
11. Cheung AK, Greene T, Leypoldt JK, Yan G, AllonM, Delmez J, Levey AS, Levin NW, Rocco MV, Schulman G, Eknoyan G; HEMO Study Group: Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 3: 69-77, 2008
12. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S, Ronco C, Vanholder R; Membrane Permeability Outcome (MPO) Study Group: Effect of membrane permeability on survival of hemodialysis patients. J AmSoc Nephrol 20: 645-654, 2009
13. Sitter T, Bergner A, Schiffl H: Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 15: 1207-1211, 2000
14. Schiffl H, Lang SM, Stratakis D, Fischer R: Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 16: 1863-1869, 2001
15. RahmatiMA,Homel P, HoenichNA, Levin R, KaysenGA, LevinNW: The role of improved water quality on inflammatory markers in patients undergoing regular dialysis. Int J Artif Organs 27: 723-727, 2004
16. Koda Y, Nishi S, Miyazaki S, Haginoshita S, Sakurabayashi T, Suzuki M, Sakai S, Yuasa Y, Hirasawa Y, Nishi T: Switch from conventional to highflux membrane reduces the risk of carpal tunnel syndrome andmortality of hemodialysis patients. Kidney Int 52: 1096-1101, 1997
17. Lederer SR, Schiffl H: Ultrapure dialysis fluid lowers the cardiovascular morbidity in patients on maintenance hemodialysis by reducing continuous microinflammation. Nephron 91: 452-455, 2002
18. AllonM, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ: Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 47: 469-477, 2006
19. Weiss MF, Erhard P, Kader-Attia FA, Wu YC, Deoreo PB, Araki A, Glomb MA, Monnier VM: Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int 57: 2571-2585, 2000
20. Wanner C, Bahner U, Mattern R, Lang D, Passlick-Deetjen J: Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patients. Nephrol Dial Transplant 19: 2570-2575, 2004
21. Ward RA: Worldwide water standards for hemodialysis. Hemodial Int 11[S1]: S18-S25, 2007
22. Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47: 139-148, 2006
23. Association for the Advancement of Medical Instrumentation: Dialysate for hemodialysis (ANSI/AAMI RD52:2004), Arlington, VA, American National Standard, 2004